All updates
All updates
today 45文献与产业新闻精选评分3636 中文产业新闻Chinese source评分6464 恒瑞医药基础胰岛素周制剂SHR-3167在EASD年会公布两项研究结果
中文产业新闻精选Chinese source评分7373 默沙东Remigromig治疗DME的BRUNELLO试验一年数据达抗VEGF非劣效
中文产业新闻Chinese source评分3434 干燥综合征新药竞争：泰它西普国内获批，艾加莫德UNITY Ⅲ期终止
中文产业新闻Chinese source评分5959 罗氏胰淀素类似物 petrelintide II 期减重 9.2% 副作用似安慰剂降糖弱于竞品
顶刊论文（社媒热度）精选评分8282 Vasopressors or Fluids in Early Septic Shock.
中文产业新闻Chinese source评分3535 复宏汉霖启动HLX37中国II/III期临床试验，针对晚期非小细胞肺癌
临床试验登记评分2727 Early Intervention for High Risk Premyopic Children
监管与产业动态评分1111 Signal or noise? > Optogenetic Therapy Could Restore Some Visual Function in Blindness - Technology Networks >> Comment below! #strategy #competitiveintelligence #marketing #biotech #healthcare #pharmaceutical #pharma #competitivemarketing
中文产业新闻精选Chinese source评分8888 赞赋®III期EXCALIBER-RRMM研究中位PFS达42个月，风险比0.49
中文产业新闻精选Chinese source评分7171 国产PDE4B抑制剂普瑞非司特III期头对头试验称赢下阿普米司特
中文产业新闻Chinese source评分3535 安进AMG133启动1300例三期，每月一针头对头叫板司美格鲁肽
中文产业新闻Chinese source评分6060 Tirabrutinib单药治疗R/R PCNSL的疗效与安全性：2期PROSPECT试验
中文产业新闻Chinese source评分6565 信达生物 IGF-1R 抗体信必敏®（IBI311）Ⅲ 期 RESTORE-3 在非活动性甲状腺眼病达到主要终点
中文产业新闻精选Chinese source评分6363 Argenx 终止 efgartigimod 干燥综合征 III 期 UNITY 试验，主要终点未达
监管与产业动态精选评分8585 Program helping patients self-regulate strong-opioid use has potential for NHS, study shows
监管与产业动态评分88 Signal or noise? > Health Rounds: Blindness treatment based on Nobel-winning research shows promise - WTVB >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #healthcare #pharmaceutical #biotech
中文产业新闻精选Chinese source评分6666 艾力斯回应伏美替尼FURVENT三期失败：称化疗组评估差异大、专家认可疗效预期
中文产业新闻精选Chinese source评分8080 众生睿创RAY1225三期双周给药达主要终点，9mg组安慰剂校正减重20.46%
中文产业新闻精选Chinese source评分8080 行业研究｜罗氏 enicepatide 24mg 48 周减重与降糖数据对标替尔泊肽
中文产业新闻Chinese source评分4848 Life Biosciences ER-100 青光眼一期临床试验公布阶段性积极数据
中文产业新闻Chinese source评分6363 MimiVax脑癌疫苗SurVaxMⅡb期SURVIVE试验未达OS主要终点，关键亚组显示生存获益
中文产业新闻精选Chinese source评分8282 国产减重双雄亮剑：RAY1225三期减重22.24% vs BGM0504三期减重19.2%
文献与产业新闻精选评分5151 Testing peripheral and central therapies for provoked vestibulodynia: results from the UPDATe trial
中文产业新闻Chinese source评分2828 Genentech的RGT-419B（CDK2/CDK4抑制剂）启动HR+/HER2-乳腺癌Ib期临床试验
中文产业新闻Chinese source评分3535 Novartis启动NIO752针对额颞叶痴呆等原发性Tau蛋白病的II期篮式试验
中文产业新闻Chinese source评分3333 科伦博泰在中国启动芦康沙妥珠单抗（SKB264）联合SKB118治疗EGFR突变非鳞状NSCLC的Ⅱ期临床试验
中文产业新闻Chinese source评分2727 诺和诺德zenagamtide启动针对2型糖尿病、肥胖及超重人群的Ⅰ期临床试验
The Lancet Oncology精选评分5252 [Articles] Invasive interval breast cancer rates after digital breast tomosynthesis plus synthesised mammography versus digital mammography screening (TOSYMA): 24-month follow-up of the multicentre, open-label, randomised, controlled, superiority trial
中文产业新闻Chinese source评分6363 众生睿创 RAY1225 注射液减重 III 期 REBUILDING-2 达主要终点
临床试验登记评分2222 BLinatumomab and iNKT in Relapsed B-Cell ALL
临床试验登记评分1919 A Study to Evaluate the Effects of GDC-4198 in Combination With Letrozole, Fulvestrant, or Giredestrant in Participants With Locally Advanced or Metastatic Hormone Receptor-Positive, HER2-Negatve Breast Cancer
临床试验登记评分1818 A Phase 1, Multiple Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HTX-001
临床试验登记评分3333 Post-traumatic Estradiol Administration and Care Evaluation (PEACE)
临床试验登记评分2828 Memantine Targeting Neurovascular Dysfunction After Mild and Moderate Traumatic Brain Injury (MEND)
临床试验登记评分3535 A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of NIO752 in Primary Tauopathies
临床试验登记评分2626 GST101 in Participants With RAS-Mutant Advanced Solid Tumors
临床试验登记评分3535 A Multicenter, Randomized, Controlled Phase III Clinical Trial on Adjuvant Intensified Therapy for Patients With Residual Disease After Neoadjuvant Treatment for Triple-negative Breast Cancer
临床试验登记评分3030 A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication
临床试验登记评分2727 Neoadjuvant Iparomlimab and Tuvonralimab With Nab-P-SOX in Locally Advanced Gastric or Gastroesophageal Junction Cancer